Breaking Finance News

Swiss Re (ETR:SR9) target bumped up to 98.00EUR, released a research note earlier today by Deutsche Bank AG

Deutsche Bank AG bumped up the target of Swiss Re (ETR:SR9) to 98.00EUR stating a potential upside of 0.14%.

On 10/07/2016, Deutsche Bank AG released a statement for Swiss Re (ETR:SR9) bumped up the target price from 0.00EUR to 98.00EUR that suggested an upside of 0.14%.

Boasting a price of 85.90EUR, Swiss Re (ETR:SR9) traded 0.00% even on the day. With the last stock price close up 0.00% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Swiss Re has recorded a 50-day average of 0.00EUR and a two hundred day average of 0.00EUR. Volume of trade held steady, with 0 shares of SR9 changing hands on par with the typical 0

Performance Chart

Swiss Re (ETR:SR9)

With a total market value of 0 EUR, Swiss Re has with a one year low of 0.00EUR and a one year high of 0.00EUR .

Brief Synopsis About Swiss Re (ETR:SR9)

Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company's clients include insurance companies, mid- to large-sized corporations and public sector clients. Its segments include Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Admin Re. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments. The Corporate Solutions segment is engaged in serving mid-sized and large corporations, with product offerings ranging from traditional property and casualty insurance to customized solutions. The Admin Re segment provides risk and capital management solutions by which the Company acquires closed books of in-force life and health insurance business, entire lines of business, or the entire capital stock of life insurance companies. The Company's open and closed life insurance books, including Admin Re, are managed under a unit called Life Capital.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *